搜索临床试验以:Bacterial growth
总计25431个结果
-
The Cleveland Clinic撤销
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Beth Israel Deaconess Medical Center完全的
-
California Cancer ConsortiumNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)终止复发性小淋巴细胞淋巴瘤 | 难治性慢性淋巴细胞白血病美国
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
University of MelbourneUniversity of Barcelona; Papua New Guinea Institute of Medical Research; The University of Western... 和其他合作者完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Chulalongkorn UniversityNational Science and Technology Development Agency, Thailand完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
University of Roma La Sapienza未知
-
National Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterCelgene Corporation完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的慢性粒单核细胞白血病 | 先前治疗过的骨髓增生异常综合征 | 继发性骨髓增生异常综合征 | 新生骨髓增生异常综合征 | 难治性贫血 | 难治性贫血伴原始细胞过多 | 转化中原始细胞过多的难治性贫血 | 环状铁粒幼细胞难治性贫血美国
-
National Cancer Institute (NCI)完全的
-
Institut de Recherche pour le DeveloppementSaint Antoine University Hospital; Ministry of Health, Benin; Sidaction; National University Hospital... 和其他合作者完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)终止复发性皮肤 T 细胞非霍奇金淋巴瘤 | 复发性蕈样肉芽肿/Sezary 综合征 | III 期皮肤 T 细胞非霍奇金淋巴瘤 | III 期蕈样肉芽肿/Sezary 综合征 | IV 期皮肤 T 细胞非霍奇金淋巴瘤 | IV 期蕈样肉芽肿/Sezary 综合征 | I 期皮肤 T 细胞非霍奇金淋巴瘤 | II 期皮肤 T 细胞非霍奇金淋巴瘤 | I 期蕈样肉芽肿/Sezary 综合征 | II 期蕈样肉芽肿/Sezary 综合征美国
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Santen Inc.MacuSight, Inc.终止
-
National Cancer Institute (NCI)完全的
-
IRCCS Burlo GarofoloUniversity of Pisa; University of Trieste; University of Messina; Università degli Studi di Brescia 和其他合作者完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Michele CavoJanssen-Cilag S.p.A.未知
-
Central European Society for Anticancer Drug Research完全的